Skip to main content

match.asia Launches Exit HealthCheck to Help SMEs Avoid Common M&A Deal Killers

Free exit readiness service helps business owners identify problem areas before entering the M&A market.

Singapore, June 04, 2026 (GLOBE NEWSWIRE) — Many SME transactions fail before completion. Buyers and sellers may struggle to align on expectations, valuation gaps can emerge during negotiations, and businesses often enter the market before they are fully prepared for due diligence. 

match.asia Launches Exit HealthCheck to Help SMEs Avoid Common M&A Deal Killers

Helps SMEs prepare for better M&A outcomes.

To help address these challenges, match.asia today announced the launch of Exit HealthCheck, a free exit readiness service designed to help SMEs identify potential gaps and improve preparedness before pursuing a sale, capital raise, or strategic transaction. 

Based on match.asia’s transaction experience, three of the most common reasons SME deals fail to progress are misalignment between buyers and sellers, valuation gaps, and inadequate preparation for the due diligence process. 

Through its growing Match NAVI AI ecosystem, match.asia is building practical solutions to address each of these challenges and improve transaction success rates. 

Following on the success of Match Value, match.asia’s free valuation service, Exit HealthCheck focuses on transaction readiness by helping SMEs assess areas commonly scrutinised by buyers and investors, including financial reporting, operational maturity, governance, management depth, customer concentration, and transaction preparedness. 

Since incorporation in 2024, match.asia has built a rapidly growing proprietary dataset and network of over 200 verified sellers and 1,000 accredited buyers across 8 markets, supporting its matching, valuation, and transaction-readiness capabilities. 

Founded by experienced dealmakers who have worked as advisers, investors, buyers, and founders, match.asia combines a wide regional buyer-seller network, proprietary matching capabilities, and hands-on M&A execution support on a success-fee-only basis. 

“Many SME owners only discover weaknesses in their business when buyers uncover them during due diligence,” said Marcus Yeung, CEO and Co-Founder of match.asia

“By that stage, valuation expectations may need to be revised, buyer confidence may be affected, and transactions can become significantly more difficult to complete. Exit HealthCheck is designed to help business owners identify these issues earlier and improve their readiness before entering the market.” 

He added:
“In our experience, many SME transactions fail because buyers and sellers are not properly aligned, valuation expectations differ, or businesses enter the M&A process before they are ready. Match NAVI AI, Match Value, and Exit HealthCheck were built to address these challenges. By improving alignment, reducing valuation misunderstandings, and helping businesses prepare earlier, we believe we can reduce wasted discussions and increase the probability of successful outcomes.” 

Business owners exploring M&A can evaluate their readiness for a future transaction at no cost via: Exit HealthCheck

About match.asia

match.asia is the end-to-end deal platform for SMEs in Asia. Founded in 2024 and headquartered in Singapore, the company connects verified sellers with aligned investors using structured data and proprietary AI matching technology, supporting every stage of the deal journey from discovery to close. For more information, visit www.match.asia.

Press Inquiries

Marcus Yeung
CEO, match.asia
contact@match.asia
https://match.asia/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.